These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 17237401)
1. BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. Arnett HA; Escobar SS; Gonzalez-Suarez E; Budelsky AL; Steffen LA; Boiani N; Zhang M; Siu G; Brewer AW; Viney JL J Immunol; 2007 Feb; 178(3):1523-33. PubMed ID: 17237401 [TBL] [Abstract][Full Text] [Related]
2. BTNL2, a butyrophilin-like molecule that functions to inhibit T cell activation. Nguyen T; Liu XK; Zhang Y; Dong C J Immunol; 2006 Jun; 176(12):7354-60. PubMed ID: 16751379 [TBL] [Abstract][Full Text] [Related]
3. Butyrophilin-like 2 modulates B7 costimulation to induce Foxp3 expression and regulatory T cell development in mature T cells. Swanson RM; Gavin MA; Escobar SS; Rottman JB; Lipsky BP; Dube S; Li L; Bigler J; Wolfson M; Arnett HA; Viney JL J Immunol; 2013 Mar; 190(5):2027-35. PubMed ID: 23359506 [TBL] [Abstract][Full Text] [Related]
4. Regulation of costimulation in the era of butyrophilins. Arnett HA; Escobar SS; Viney JL Cytokine; 2009 Jun; 46(3):370-5. PubMed ID: 19380239 [TBL] [Abstract][Full Text] [Related]
5. A butyrophilin family member critically inhibits T cell activation. Yamazaki T; Goya I; Graf D; Craig S; Martin-Orozco N; Dong C J Immunol; 2010 Nov; 185(10):5907-14. PubMed ID: 20944003 [TBL] [Abstract][Full Text] [Related]
6. B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. Liu Z; Geboes K; Hellings P; Maerten P; Heremans H; Vandenberghe P; Boon L; van Kooten P; Rutgeerts P; Ceuppens JL J Immunol; 2001 Aug; 167(3):1830-8. PubMed ID: 11466409 [TBL] [Abstract][Full Text] [Related]
7. BTNL8, a butyrophilin-like molecule that costimulates the primary immune response. Chapoval AI; Smithson G; Brunick L; Mesri M; Boldog FL; Andrew D; Khramtsov NV; Feshchenko EA; Starling GC; Mezes PS Mol Immunol; 2013 Dec; 56(4):819-28. PubMed ID: 24036152 [TBL] [Abstract][Full Text] [Related]
8. The T-Cell Inhibitory Molecule Butyrophilin-Like 2 Is Up-regulated in Mild Plasmodium falciparum Infection and Is Protective During Experimental Cerebral Malaria. Subramaniam KS; Spaulding E; Ivan E; Mutimura E; Kim RS; Liu X; Dong C; Feintuch CM; Zhang X; Anastos K; Lauvau G; Daily JP J Infect Dis; 2015 Oct; 212(8):1322-31. PubMed ID: 25883389 [TBL] [Abstract][Full Text] [Related]
9. Genetic impact of a butyrophilin-like 2 (BTNL2) gene variation on specific IgE responsiveness to Dermatophagoides farinae (Der f) in Japanese. Konno S; Takahashi D; Hizawa N; Hattori T; Takahashi A; Isada A; Maeda Y; Huang SK; Nishimura M Allergol Int; 2009 Mar; 58(1):29-35. PubMed ID: 19050377 [TBL] [Abstract][Full Text] [Related]
10. N-terminal ectodomain of BTNL2 inhibits T cell activation via a non-canonical interaction with its putative receptor that results in a delayed progression of DSS-induced ulcerative colitis. Hansda A; Goswami S; Mukherjee S; Basak AJ; Dasgupta S; Roy PK; Samanta D; Mukherjee G Mol Immunol; 2024 Feb; 166():39-49. PubMed ID: 38219401 [TBL] [Abstract][Full Text] [Related]
11. Regulation of Immunity by Butyrophilins. Rhodes DA; Reith W; Trowsdale J Annu Rev Immunol; 2016 May; 34():151-72. PubMed ID: 26772212 [TBL] [Abstract][Full Text] [Related]
13. The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. Rennert P; Furlong K; Jellis C; Greenfield E; Freeman GJ; Ueda Y; Levine B; June CH; Gray GS Int Immunol; 1997 Jun; 9(6):805-13. PubMed ID: 9199963 [TBL] [Abstract][Full Text] [Related]
14. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502. Mochida A; Kinouchi Y; Negoro K; Takahashi S; Takagi S; Nomura E; Kakuta Y; Tosa M; Shimosegawa T Tissue Antigens; 2007 Aug; 70(2):128-35. PubMed ID: 17610417 [TBL] [Abstract][Full Text] [Related]
15. Murine B7-2, an alternative CTLA4 counter-receptor that costimulates T cell proliferation and interleukin 2 production. Freeman GJ; Borriello F; Hodes RJ; Reiser H; Gribben JG; Ng JW; Kim J; Goldberg JM; Hathcock K; Laszlo G J Exp Med; 1993 Dec; 178(6):2185-92. PubMed ID: 7504059 [TBL] [Abstract][Full Text] [Related]
16. Functional expression of a costimulatory B7.2 (CD86) protein on human salivary gland epithelial cells that interacts with the CD28 receptor, but has reduced binding to CTLA4. Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN J Immunol; 2001 Mar; 166(5):3107-13. PubMed ID: 11207262 [TBL] [Abstract][Full Text] [Related]
17. Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Valentonyte R; Hampe J; Huse K; Rosenstiel P; Albrecht M; Stenzel A; Nagy M; Gaede KI; Franke A; Haesler R; Koch A; Lengauer T; Seegert D; Reiling N; Ehlers S; Schwinger E; Platzer M; Krawczak M; Müller-Quernheim J; Schürmann M; Schreiber S Nat Genet; 2005 Apr; 37(4):357-64. PubMed ID: 15735647 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of inducible costimulator-ligand splice variants: lymphoid regulation of mouse GL50-B and human GL50 molecules. Ling V; Wu PW; Miyashiro JS; Marusic S; Finnerty HF; Collins M J Immunol; 2001 Jun; 166(12):7300-8. PubMed ID: 11390480 [TBL] [Abstract][Full Text] [Related]
19. MRC OX-2 defines a novel T cell costimulatory pathway. Borriello F; Lederer J; Scott S; Sharpe AH J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466 [TBL] [Abstract][Full Text] [Related]
20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]